Genetic and/or epigenetic analysis of the upstream enhancer regions in breast and pancreatic cancers, which were functionally validated in this study, may lead to the understanding of the mechanism by which MUC5AC and/or MUC5B is induced in those cancers. Here, MUC5B is linked to familial pancreatic carcinoma.